Vitamins with Tirzepatide | PlexusDx Nutrition Guide

Last reviewed: May 24, 2026

Last updated: May 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Tirzepatide modifies appetite and gastric emptying, which can alter nutrient absorption and increase micronutrient demands. Supporting your body with targeted vitamins during treatment requires understanding your baseline nutritional status and how your individual physiology responds to GLP-1 receptor agonism.

PlexusDx emphasizes precision nutrition—pairing clinical evidence with biomarker data and genetic insights to help you and your provider design a supplementation strategy tailored to your unique needs, not generic recommendations applicable to everyone.

How Tirzepatide Affects Nutrient Absorption and Status

Tirzepatide delays gastric emptying and reduces overall food intake, creating two distinct mechanisms that challenge micronutrient status. Slower digestion can reduce absorption efficiency for certain vitamins, while reduced caloric intake lowers total micronutrient consumption unless meals are nutrient-dense.

Research in GLP-1 agonist users shows relative increases in deficiency risk for vitamin B12, folate, iron, calcium, and vitamin D. Individual risk varies based on baseline diet quality, genetic absorption capacity, and pre-existing marginal deficiencies—factors a qualified provider should assess before and during treatment.

Essential Micronutrients and Tirzepatide: Evidence-Based Framework

Personalizing supplementation begins with understanding which nutrients are most vulnerable during tirzepatide use and why. The table below outlines key micronutrients, their role in metabolic health, and the rationale for monitoring or supplementing during treatment.

Micronutrient	Role in Health	Tirzepatide-Related Risk	Provider Monitoring Approach
Vitamin B12	Energy metabolism, neurologic function	Reduced intrinsic factor or food intake; absorption slowed by delayed gastric transit	Baseline serum B12 or methylmalonic acid; annual checks during therapy
Folate	DNA synthesis, cell division, homocysteine metabolism	Reduced dietary intake from lower food volume; malabsorption in proximal small intestine	Baseline serum folate; monitor if anemia symptoms emerge
Iron	Oxygen transport, mitochondrial function	Reduced gastric acid from slower emptying may impair non-heme iron absorption; lower meat intake	Baseline ferritin, serum iron, TIBC; supplementation timing critical (separate from calcium)
Calcium & Vitamin D	Bone density, immune and metabolic signaling	Reduced dairy intake; impaired absorption from altered GI transit and lower vitamin D synthesis	Baseline 25-OH vitamin D; consider supplementation, especially if sun exposure limited

Building a Tirzepatide-Aware Supplementation Strategy

Effective supplementation during tirzepatide therapy requires baseline biomarker assessment, strategic timing, and form selection. A qualified provider should order comprehensive metabolic panels and micronutrient markers before treatment initiation to establish your starting point and identify pre-existing deficiencies.

Supplement timing and form matter significantly—vitamin B12 (sublingual or intramuscular), iron (separate from calcium by at least 2 hours), and vitamin D (fat-soluble, taken with a meal) all have absorption-specific considerations. Your provider can recommend dosing adjusted for delayed gastric transit and reduced meal volume.

Genetic Predispositions and Individual Absorption Capacity

Some patients carry genetic variations that affect nutrient absorption, metabolism, or demand even before tirzepatide. Variants in genes encoding B12-binding proteins, iron transporters, and vitamin D-responsive elements can increase baseline deficiency risk and warrant proactive supplementation during GLP-1 therapy.

Your provider should evaluate personal and family history of anemia, bone health concerns, or neurologic symptoms—red flags for absorption or metabolism challenges. Combined with genetic insights, this clinical context can guide preventive supplementation and more frequent monitoring intervals.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context about your genetic predispositions in absorption and metabolic pathways relevant to nutrient status. Variants in genes related to nutrient transporter function, folate metabolism, and vitamin D signaling can inform your provider's supplementation decisions and monitoring schedule.

The test reveals genetic predispositions—not exact supplementation needs or guaranteed responses. Your individual biomarkers (serum B12, folate, iron status, vitamin D) are the primary drivers of supplementation decisions. Genetic insights should be interpreted with a qualified healthcare provider as one input among many.

Combining baseline biomarker data, genetic predisposition screening, and tirzepatide-specific GI changes creates a comprehensive picture. This integration can support a more informed conversation with your provider about whether supplementation is preventive, therapeutic, or both—and at what doses and intervals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.